Data from Hengrui’s Phase II trial for its GLP-1/GIP product demonstrated a statistically significant mean weight loss of ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...

The following is a summary of “Treatment of Hypothalamic Obesity With GLP-1 Analogs,” published in the November 2024 issue of Endocrinology by Dimitri and Roth. Damage to hypothalamic nuclei or ...

In short, LifeVantage is riding the coattails of Eli Lilly's (LLY) GLP-1 agonist blockbuster weight-loss drug Zepbound with ... Investor's Edge provides the world's best energy, shipping, and ...

Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation ...

giving patients expert guidance and monitoring throughout their weight loss journey. "Our service helps patients achieve their goals safely, with the reassurance of personalised care from experienced ...

A study found that disruptions in homeostasis from quick weight reduction by consuming GLP-1 drug can elevate cortisol - a ...

Many providers are familiar with the latest weight-loss injections ... Its active ingredient is semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that acts like the GLP-1 hormone ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

GLP-1 drugs have been shown to help people lose weight They also can help lower blood sugar and protect heart health The drugs work in different ways in the body to cause these effects THURSDAY ...